Home
About
Past Meetings - Notes and Presentations
Sponsors & Volunteers
Seminar Conveners
Important Links
Directions & Parking
Contact Info
Background information on this month's topic
LAM Research: New Insights & Unanswered Questions
Dr. Joel Moss is a principal investigator at the National Heart Lung and Blood Institute at the National Institutes of Health. Research in his laboratory is focused on signal transduction pathways in LAM. He also sees the largest number of LAM patients of any clinician in the United States.
Dr. Myles Brown is Professor of Medicine at Harvard Medical School. The overall aim of his lab's research is the elucidation of the factors underlying the hormonal reposonsiveness of human cancers. This work is focused primarily on the role of steroid hormone receptors and their coregulators.
Dr. George Demetri is Associate Professor of Medicine at Harvard Medical School. His work centers on molecular targeted agents and signal transduction inhibitors. A major aim of the work in his lab is to translate the basic biology of sarcomas into new therapeutics directed at novel targets.
Please join us Thursday, November 30th as Dr. Joel Moss (NIH-NHLBI) discusses key challenges in research on Lymphangioleiomyomatosis (LAM). Dr Myles Brown and Dr. George Demetri will be discussants and facilitate exchange on topics raised by this talk and potential therapeutic interventions. Following this forum, we will break for a light dinner with continued informal discussion.
Date: Thursday, November 30th, 2006 5:00-7:00 PM
Location: New Research Building, Harvard Medical School
77 Avenue Louis Pasteur, Room 350
Parking: : Free parking in the lot below the New Research Building has been graciously donated. Space is limited and will be made available to participants coming from outside of the Longwood Medical Area, if requested by November 28th.
Please RSVP to amy_farber@hms.harvard.edu and indicate the number of people attending. If you would like a 30 minute meeting with Joel Moss on November 30th, please email Amy Farber at amy_farber@hms.harvard.edu as soon as possible.
We appreciate your help in forwarding this announcement to relevant researchers, labs and clinicians.
Thank you for your interest and participation!
Best Regards,
David Kwiatkowski, Amy Farber and Michael Nurok
